159 related articles for article (PubMed ID: 33836245)
1. MicroRNA-4422-5p as a Negative Regulator of Amyloidogenic Secretases: A Potential Biomarker for Alzheimer's Disease.
Hajjari SN; Sadigh-Eteghad S; Shanehbandi D; Teimourian S; Shahbazi A; Mehdizadeh M
Neuroscience; 2021 May; 463():108-115. PubMed ID: 33836245
[TBL] [Abstract][Full Text] [Related]
2. miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells.
Zhang N; Li WW; Lv CM; Gao YW; Liu XL; Zhao L
Neuroreport; 2020 Feb; 31(3):205-212. PubMed ID: 31876684
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects.
Long JM; Ray B; Lahiri DK
J Biol Chem; 2014 Feb; 289(8):5184-98. PubMed ID: 24352696
[TBL] [Abstract][Full Text] [Related]
4. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
[TBL] [Abstract][Full Text] [Related]
5. miR-15b reduces amyloid-β accumulation in SH-SY5Y cell line through targetting NF-κB signaling and BACE1.
Li J; Wang H
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29961672
[TBL] [Abstract][Full Text] [Related]
6. Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
Zhang J; Wang R
Exp Gerontol; 2021 Feb; 144():111180. PubMed ID: 33279663
[TBL] [Abstract][Full Text] [Related]
7. Circulating Small Extracellular Vesicle-Derived miR-342-5p Ameliorates Beta-Amyloid Formation via Targeting Beta-site APP Cleaving Enzyme 1 in Alzheimer's Disease.
Dong Z; Gu H; Guo Q; Liu X; Li F; Liu H; Sun L; Ma H; Zhao K
Cells; 2022 Nov; 11(23):. PubMed ID: 36497090
[TBL] [Abstract][Full Text] [Related]
8. miR-34a-5p and miR-125b-5p attenuate Aβ-induced neurotoxicity through targeting BACE1.
Li P; Xu Y; Wang B; Huang J; Li Q
J Neurol Sci; 2020 Jun; 413():116793. PubMed ID: 32251872
[TBL] [Abstract][Full Text] [Related]
9. miR-186 is decreased in aged brain and suppresses BACE1 expression.
Kim J; Yoon H; Chung DE; Brown JL; Belmonte KC; Kim J
J Neurochem; 2016 May; 137(3):436-45. PubMed ID: 26710318
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
Liu CG; Wang JL; Li L; Wang PC
Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
[TBL] [Abstract][Full Text] [Related]
11. miR-98-5p Acts as a Target for Alzheimer's Disease by Regulating Aβ Production Through Modulating SNX6 Expression.
Li Q; Li X; Wang L; Zhang Y; Chen L
J Mol Neurosci; 2016 Dec; 60(4):413-420. PubMed ID: 27541017
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1.
Zhu HC; Wang LM; Wang M; Song B; Tan S; Teng JF; Duan DX
Brain Res Bull; 2012 Sep; 88(6):596-601. PubMed ID: 22721728
[TBL] [Abstract][Full Text] [Related]
13. Beta-Amyloid-Dependent miRNAs as Circulating Biomarkers in Alzheimer's Disease: a Preliminary Report.
Hajjri SN; Sadigh-Eteghad S; Mehrpour M; Moradi F; Shanehbandi D; Mehdizadeh M
J Mol Neurosci; 2020 Jun; 70(6):871-877. PubMed ID: 32306293
[TBL] [Abstract][Full Text] [Related]
14. The long-non-coding RNA NEAT1 is a novel target for Alzheimer's disease progression via miR-124/BACE1 axis.
Zhao MY; Wang GQ; Wang NN; Yu QY; Liu RL; Shi WQ
Neurol Res; 2019 Jun; 41(6):489-497. PubMed ID: 31014193
[TBL] [Abstract][Full Text] [Related]
15. Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease.
Lei X; Lei L; Zhang Z; Zhang Z; Cheng Y
Int J Clin Exp Pathol; 2015; 8(2):1565-74. PubMed ID: 25973041
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA AXL increases neuron injury and inflammation through targeting microRNA-328 mediated BACE1 in Alzheimer's disease.
Li Y; Han X; Fan H; Sun J; Ni M; Zhang L; Fang F; Zhang W; Ma P
Neurosci Lett; 2022 Apr; 776():136531. PubMed ID: 35167942
[TBL] [Abstract][Full Text] [Related]
17. Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease.
Qian Q; Zhang J; He FP; Bao WX; Zheng TT; Zhou DM; Pan HY; Zhang H; Zhang XQ; He X; Sun BG; Luo BY; Chen C; Peng GP
FASEB J; 2019 Mar; 33(3):4404-4417. PubMed ID: 30576233
[TBL] [Abstract][Full Text] [Related]
18. The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease.
Fang M; Wang J; Zhang X; Geng Y; Hu Z; Rudd JA; Ling S; Chen W; Han S
Toxicol Lett; 2012 Feb; 209(1):94-105. PubMed ID: 22178568
[TBL] [Abstract][Full Text] [Related]
19. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression.
Hébert SS; Horré K; Nicolaï L; Papadopoulou AS; Mandemakers W; Silahtaroglu AN; Kauppinen S; Delacourte A; De Strooper B
Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6415-20. PubMed ID: 18434550
[TBL] [Abstract][Full Text] [Related]
20. MiR-361-3p inhibits β-amyloid accumulation and attenuates cognitive deficits through targeting BACE1 in Alzheimer's disease.
Ji Y; Wang D; Zhang B; Lu H
J Integr Neurosci; 2019 Sep; 18(3):285-291. PubMed ID: 31601077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
